UBS Group’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8K | Sell |
|
|||||
|
2025
Q1 | $76.1K | Sell |
|
|||||
|
2024
Q4 | $273K | Buy |
|
|||||
|
2024
Q3 | $68.8K | Buy |
|
|||||
|
2024
Q2 | $23.9K | Buy |
|
|||||
|
2024
Q1 | $13.6K | Sell |
|
|||||
|
2023
Q4 | $11.7K | Sell |
|
|||||
|
2023
Q3 | $16.2K | Buy |
|
|||||
|
2023
Q2 | $22K | Sell |
|
|||||
|
2023
Q1 | $216K | Buy |
|
|||||
|
2022
Q4 | $129K | Buy |
|
|||||
|
2022
Q3 | $54K | Buy |
|
|||||
|
2022
Q2 | $21K | Buy |
|
|||||
|
2022
Q1 | $26K | Sell |
|
|||||
|
2021
Q4 | $195K | Buy |
|
|||||
|
2021
Q3 | $26K | Sell |
|
|||||
|
2021
Q2 | $357K | Buy |
|
|||||
|
2021
Q1 | $18K | Buy |
|
|||||
|
2020
Q4 | $1K | Sell |
|
|||||
|
2020
Q3 | $24K | Buy |
|
|||||
|
2020
Q2 | $15K | Sell |
|
|||||
|
2020
Q1 | $24K | Buy |
|
|||||
|
2019
Q4 | $1K | Sell |
|
|||||
|
2019
Q3 | $6K | Sell |
|
|||||
|
2019
Q2 | $7K | Buy |
|
|||||
|
2019
Q1 | $5K | Sell |
|
|||||
|
2018
Q4 | $9K | Sell |
|
|||||
|
2018
Q3 | $16K | Sell |
|
|||||
|
2018
Q2 | $61K | Sell |
|
|||||
|
2018
Q1 | $57K | Sell |
|
|||||
|
2017
Q4 | $157K | Buy |
|
|||||
|
2017
Q3 | $25K | Buy |
|
|||||
|
2017
Q2 | $2K | Sell |
|
|||||
|
2017
Q1 | $3K | Sell |
|
|||||
|
2016
Q4 | $8K | Sell |
|
|||||
|
2016
Q3 | $14K | Buy |
|
|||||
|
2016
Q2 | $5K | Sell |
|
|||||
|
2016
Q1 | $8K | Buy |
|
|||||
|
2015
Q4 | $5K | Hold |
|
|||||
|
2015
Q3 | $3K | Sell |
|
|||||
|
2015
Q2 | $20K | Buy |
|
|||||
|
2015
Q1 | $17K | Buy |
|
|||||
|
2014
Q4 | $7K | Buy |
|